AUPH - Potential Positive Readout Of Aurinia Pharmaceuticals' Phase 2/3 AUDREY Trial Could Bring Best-In-Class Eye Drops For Dry Eye Syndrome
The Dry Eye Syndrome is a relatively common disease whose prevalence increases as people age. It is believed that more than 6% of the population over age of 40 and 15% of the population over age of 65 is impacted by DES in US, with symptoms that vary from mild (redness, irritation, etc.) to severe (cornea scarring and blurred vision).
DES was originally recognized mainly as an exocrine disease, where the fast drying of the corneal surface was believed to be caused by aqueous production deficiency, where the lacrimal gland under the upper eyelids does